Elisabeth Crönert-Bendell
Corporate Officer/Principal presso RHYTHM PHARMACEUTICALS, INC.
Posizioni attive di Elisabeth Crönert-Bendell
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2021 | - |
Storia della carriera di Elisabeth Crönert-Bendell
Precedenti posizioni note di Elisabeth Crönert-Bendell
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SANOFI | Corporate Officer/Principal | - | - |
Kyowa Kirin International Plc
 Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Corporate Officer/Principal | - | - |
Formazione di Elisabeth Crönert-Bendell
| INSEAD | Masters Business Admin |
Statistiche
Distribuzione geografica
| Francia | 3 |
| Stati Uniti | 2 |
| Regno Unito | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| SANOFI | Health Technology |
| Aziende private | 1 |
|---|---|
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Health Technology |
